Relmada Therapeutics, Inc. RLMD Cashless Exercise Of Warrant For Common Stock
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlmd:CashlessExerciseOfWarrantForCommonStock.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s cashless exercise of warrant for common stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s cashless exercise of warrant for common stock?
- Relmada Therapeutics, Inc. (RLMD) reported cashless exercise of warrant for common stock of -$2.08K in Q1 2026.